JP2019523761A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019523761A5 JP2019523761A5 JP2018562186A JP2018562186A JP2019523761A5 JP 2019523761 A5 JP2019523761 A5 JP 2019523761A5 JP 2018562186 A JP2018562186 A JP 2018562186A JP 2018562186 A JP2018562186 A JP 2018562186A JP 2019523761 A5 JP2019523761 A5 JP 2019523761A5
- Authority
- JP
- Japan
- Prior art keywords
- pab
- adc
- ala
- formula
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021143103A JP7403507B2 (ja) | 2016-05-31 | 2021-09-02 | 薬物としてアマトキシンの誘導体を有する抗体薬物コンジュゲート |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662343825P | 2016-05-31 | 2016-05-31 | |
| US62/343,825 | 2016-05-31 | ||
| PCT/US2017/035206 WO2017210288A1 (en) | 2016-05-31 | 2017-05-31 | Antibody drug conjugates having derivatives of amatoxin as the drug |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021143103A Division JP7403507B2 (ja) | 2016-05-31 | 2021-09-02 | 薬物としてアマトキシンの誘導体を有する抗体薬物コンジュゲート |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019523761A JP2019523761A (ja) | 2019-08-29 |
| JP2019523761A5 true JP2019523761A5 (enExample) | 2020-07-09 |
| JP7103953B2 JP7103953B2 (ja) | 2022-07-20 |
Family
ID=60421192
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018562186A Active JP7103953B2 (ja) | 2016-05-31 | 2017-05-31 | 薬物としてアマトキシンの誘導体を有する抗体薬物コンジュゲート |
| JP2021143103A Active JP7403507B2 (ja) | 2016-05-31 | 2021-09-02 | 薬物としてアマトキシンの誘導体を有する抗体薬物コンジュゲート |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021143103A Active JP7403507B2 (ja) | 2016-05-31 | 2021-09-02 | 薬物としてアマトキシンの誘導体を有する抗体薬物コンジュゲート |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11013816B2 (enExample) |
| EP (1) | EP3471771A4 (enExample) |
| JP (2) | JP7103953B2 (enExample) |
| CN (2) | CN109195631B (enExample) |
| CA (1) | CA3025931A1 (enExample) |
| WO (1) | WO2017210288A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3471771A4 (en) * | 2016-05-31 | 2020-04-15 | Sorrento Therapeutics, Inc. | ANTIBODY CONJUGATES HAVING AMATOXIN DERIVATIVES AS A MEDICINAL PRODUCT |
| JP2019522050A (ja) | 2016-06-17 | 2019-08-08 | マジェンタ セラピューティクス インコーポレイテッドＭａｇｅｎｔａ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． | 細胞の枯渇のための組成物および方法 |
| US10576161B2 (en) | 2017-01-20 | 2020-03-03 | Magenta Therapeutics, Inc. | Compositions and methods for the depletion of CD137+ cells |
| JP2021521202A (ja) * | 2018-04-13 | 2021-08-26 | ハイデルベルク ファルマ リサーチ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 固形腫瘍の治療のための標的化されたアマトキシン複合体 |
| KR20210117302A (ko) * | 2019-01-31 | 2021-09-28 | 항저우 디에이씨 바이오테크 씨오, 엘티디 | 분지형 링커를 갖는 아마니타 독소의 접합체 |
| WO2020216947A1 (en) * | 2019-04-24 | 2020-10-29 | Heidelberg Pharma Research Gmbh | Amatoxin antibody-drug conjugates and uses thereof |
| JP2022539076A (ja) * | 2019-06-24 | 2022-09-07 | ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ． | 分岐連結体を有する細胞結合分子と細胞毒性剤との共役体 |
| CN115103858B (zh) * | 2020-03-25 | 2025-07-15 | 江苏恒瑞医药股份有限公司 | 一种抗体药物偶联物的制备方法 |
| CA3210069A1 (en) | 2021-03-03 | 2022-09-09 | Tong Zhu | Antibody-drug conjugates comprising an anti-bcma antibody |
| CN117241832A (zh) | 2021-03-19 | 2023-12-15 | 海德堡医药研究有限责任公司 | B淋巴细胞特异性的鹅膏毒素抗体缀合物 |
| CN113980909B (zh) * | 2021-11-16 | 2022-06-14 | 江南大学 | 一种α-鹅膏蕈碱人工抗原、单克隆抗体、杂交瘤细胞株及应用 |
| WO2023173026A1 (en) | 2022-03-10 | 2023-09-14 | Sorrento Therapeutics, Inc. | Antibody-drug conjugates and uses thereof |
| WO2024211235A1 (en) | 2023-04-05 | 2024-10-10 | Sorrento Therapeutics, Inc. | Antibody-drug conjugates and uses thereof |
| WO2024211234A1 (en) | 2023-04-05 | 2024-10-10 | Sorrento Therapeutics, Inc. | Antibody-drug conjugates and uses thereof |
| WO2024211236A2 (en) | 2023-04-05 | 2024-10-10 | Sorrento Therapeutics, Inc. | Antibody-drug conjugates and uses thereof |
| WO2024243706A1 (en) * | 2023-06-02 | 2024-12-05 | The University Of British Columbia | Amatoxin analogs and uses thereof |
| CN117683079B (zh) * | 2023-12-12 | 2025-04-04 | 九洲药业(杭州)有限公司 | 一种抗体偶联药物连接子的固相合成方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA06013413A (es) * | 2004-05-19 | 2007-01-23 | Medarex Inc | Enlazadores quimicos y conjugados de los mismos. |
| EP3192529B1 (en) * | 2009-04-08 | 2020-03-25 | Faulstich, Heinz, Dr. | Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy |
| FR2947320B1 (fr) * | 2009-06-30 | 2011-07-22 | Valeo Systemes Thermiques | Vanne de commande pour un circuit de refroidissement d'un moteur de vehicule automobile |
| ES2402254T3 (es) * | 2010-09-30 | 2013-04-30 | Heidelberg Pharma Ag | Conjugados de amatoxinas con ligadores mejorados |
| EP2849797B1 (en) * | 2012-05-15 | 2019-12-18 | Concortis Biosystems, Corp | Drug-conjugates, conjugation methods, and uses thereof |
| WO2014043403A1 (en) * | 2012-09-12 | 2014-03-20 | Agensys, Inc. | Amatoxin derivatives and cell-permeable conjugates thereof as inhibitors of rna polymerase |
| US9884126B2 (en) * | 2013-05-31 | 2018-02-06 | Genentech, Inc. | Anti-wall teichoic antibodies and conjugates |
| WO2015057876A1 (en) | 2013-10-15 | 2015-04-23 | Sorrento Therapeutics Inc. | Drug-conjugates with a targeting molecule and two different drugs |
| US9239324B2 (en) * | 2013-12-06 | 2016-01-19 | Gang Chen | Antibody-binding protein-drug conjugate and methods of use |
| AU2014364927A1 (en) * | 2013-12-16 | 2016-07-07 | Genentech, Inc. | Peptidomimetic compounds and antibody-drug conjugates thereof |
| EP3164420A4 (en) | 2014-06-30 | 2018-05-23 | Tarveda Therapeutics, Inc. | Targeted conjugates and particles and formulations thereof |
| AU2015282627B2 (en) | 2014-06-30 | 2020-04-02 | Glykos Finland Oy | Saccharide derivative of a toxic payload and antibody conjugates thereof |
| EP3471771A4 (en) * | 2016-05-31 | 2020-04-15 | Sorrento Therapeutics, Inc. | ANTIBODY CONJUGATES HAVING AMATOXIN DERIVATIVES AS A MEDICINAL PRODUCT |
-
2017
- 2017-05-31 EP EP17807392.0A patent/EP3471771A4/en active Pending
- 2017-05-31 US US15/609,858 patent/US11013816B2/en not_active Expired - Fee Related
- 2017-05-31 WO PCT/US2017/035206 patent/WO2017210288A1/en not_active Ceased
- 2017-05-31 CN CN201780033085.5A patent/CN109195631B/zh active Active
- 2017-05-31 CA CA3025931A patent/CA3025931A1/en active Pending
- 2017-05-31 CN CN202211405532.4A patent/CN115645544A/zh active Pending
- 2017-05-31 JP JP2018562186A patent/JP7103953B2/ja active Active
-
2021
- 2021-04-26 US US17/240,700 patent/US20210260211A1/en not_active Abandoned
- 2021-09-02 JP JP2021143103A patent/JP7403507B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019523761A5 (enExample) | ||
| US10792328B2 (en) | Nanocomplexes for delivery of saporin | |
| JP2020063241A5 (enExample) | ||
| JP2019512478A5 (enExample) | ||
| RU2654210C2 (ru) | Нацеливающие аминокислотные липиды | |
| JP2021073272A5 (enExample) | ||
| JP2021100937A5 (enExample) | ||
| JP2016505586A5 (enExample) | ||
| JP2008508315A5 (enExample) | ||
| JP2010526091A5 (enExample) | ||
| WO2008134761A2 (en) | Modification of biological targeting groups for the treatment of cancer | |
| JP2016153410A5 (enExample) | ||
| PL184342B1 (pl) | Nowe podstawione pochodne purynylowe o aktywności immunomodulującej oraz kompozycja farmaceutyczna je zawierająca | |
| JP2018526321A5 (enExample) | ||
| JP2010521485A5 (enExample) | ||
| JP2017512752A5 (enExample) | ||
| CA2408008A1 (en) | Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin | |
| JP2014528466A5 (enExample) | ||
| US20190284346A1 (en) | Novel cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and method for preparing same | |
| JP2020508985A5 (enExample) | ||
| JP2002543202A5 (enExample) | ||
| ES2774662T3 (es) | Derivados de Pt (IV) y nanotransportadores que los comprenden | |
| US20090069220A1 (en) | Dna-binding polyamide drug conjugates | |
| CN103655517A (zh) | 一种Pep-1肽修饰的脑胶质瘤靶向纳米递药系统及其制备方法 | |
| CN102781478A (zh) | 用于细胞内靶向增殖和蛋白质合成的聚阴离子多价大分子 |